1212 related articles for article (PubMed ID: 23568993)
1. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
3. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
4. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
[TBL] [Abstract][Full Text] [Related]
5. [Idiopathic Inflammatory Myopathy and Anti-aminoacyl-tRNA Synthetase Antibody].
Maeda MH
Brain Nerve; 2018 Apr; 70(4):439-448. PubMed ID: 29632291
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
Mimori T; Imura Y; Nakashima R; Yoshifuji H
Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
Mahler M; Miller FW; Fritzler MJ
Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
Hirakata M
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
[TBL] [Abstract][Full Text] [Related]
10. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
11. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies.
Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T
Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibody profile in myositis].
Allenbach Y; Benveniste O
Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of myositis-specific autoantibodies.
Nakashima R
Immunol Med; 2018 Sep; 41(3):103-112. PubMed ID: 30938275
[TBL] [Abstract][Full Text] [Related]
14. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in polymyositis and dermatomyositis.
Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
[TBL] [Abstract][Full Text] [Related]
16. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
[TBL] [Abstract][Full Text] [Related]
18. [Antisynthetase syndrome].
Gran JT
Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2270-2. PubMed ID: 12448266
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases.
Phuong TNT; Ngoc LNT; Rönnelid J; Padyukov L; Lundberg IE
Int J Rheum Dis; 2021 May; 24(5):663-670. PubMed ID: 33788398
[TBL] [Abstract][Full Text] [Related]
20. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
